G-Pen Mini™ (glucagon injection)

DRUG3 trials

Sponsors

Xeris Pharmaceuticals, Jaeb Center for Health Research

Conditions

Diabetes Mellitus, Type 1Hypoglycemia

Phase 2

Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

CompletedNCT02081014

Xeris PharmaceuticalsHypoglycemia

Start: 2014-03-31End: 2014-11-30Updated: 2018-04-05

Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

CompletedNCT02411578

Jaeb Center for Health ResearchDiabetes Mellitus, Type 1

Start: 2015-09-30End: 2016-05-31Updated: 2020-03-03

The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

CompletedNCT02660242

Jaeb Center for Health ResearchDiabetes Mellitus, Type 1

Start: 2016-01-31End: 2017-02-15Updated: 2020-03-03